118 related articles for article (PubMed ID: 6171698)
1. Antigen-specific suppressor cells in subclinical leprosy infection.
Stoner GL; Atlaw T; Touw J; Belehu A
Lancet; 1981 Dec 19-26; 2(8260-61):1372-7. PubMed ID: 6171698
[TBL] [Abstract][Full Text] [Related]
2. M. leprae and PPD-triggered T cell lines in tuberculoid and lepromatous leprosy.
Shankar P; Agis F; Wallach D; Flageul B; Cottenot F; Augier J; Bach MA
J Immunol; 1986 Jun; 136(11):4255-63. PubMed ID: 2422278
[TBL] [Abstract][Full Text] [Related]
3. T cell responses to fractionated Mycobacterium leprae antigens in leprosy. The lepromatous nonresponder defect can be overcome in vitro by stimulation with fractionated M. leprae components.
Ottenhoff TH; Converse PJ; Gebre N; Wondimu A; Ehrenberg JP; Kiessling R
Eur J Immunol; 1989 Apr; 19(4):707-13. PubMed ID: 2659369
[TBL] [Abstract][Full Text] [Related]
4. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants.
Reitan LJ; Closs O; Belehu A
Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):455-67. PubMed ID: 6763003
[TBL] [Abstract][Full Text] [Related]
5. Genetically restricted suppressor T-cell clones derived from lepromatous leprosy lesions.
Modlin RL; Kato H; Mehra V; Nelson EE; Fan XD; Rea TH; Pattengale PK; Bloom BR
Nature; 1986 Jul 31-Aug 6; 322(6078):459-61. PubMed ID: 2942780
[TBL] [Abstract][Full Text] [Related]
6. In vitro stimulation of lymphocytes in leprosy patients, healthy contacts of leprosy patients, and subjects not exposed to leprosy. Comparison of an antigen fraction prepared from Mycobacterium leprae and tuberculin-purified protein derivative.
Closs O; Reitan LJ; Negassi K; Harboe M; Belehu A
Scand J Immunol; 1982 Aug; 16(2):103-15. PubMed ID: 6182610
[TBL] [Abstract][Full Text] [Related]
7. Immunological unresponsiveness in leprosy.
Bloom BR; Mehra V
Immunol Rev; 1984 Aug; 80():5-28. PubMed ID: 6208143
[TBL] [Abstract][Full Text] [Related]
8. Cloned suppressor T cells from a lepromatous leprosy patient suppress Mycobacterium leprae reactive helper T cells.
Ottenhoff TH; Elferink DG; Klatser PR; de Vries RR
Nature; 1986 Jul 31-Aug 6; 322(6078):462-4. PubMed ID: 2426597
[TBL] [Abstract][Full Text] [Related]
9. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
[TBL] [Abstract][Full Text] [Related]
10. T cell defect in lepromatous leprosy is reversible in vitro in the absence of exogenous growth factors.
Mohagheghpour N; Gelber RR; Engleman EG
J Immunol; 1987 Jan; 138(2):570-4. PubMed ID: 2947952
[TBL] [Abstract][Full Text] [Related]
11. The suppressive effect of M. leprae on the in vitro proliferative responses of lymphocytes from patients with leprosy.
Nath I; Singh R
Clin Exp Immunol; 1980 Sep; 41(3):406-14. PubMed ID: 7002396
[TBL] [Abstract][Full Text] [Related]
12. Natural suppressor cells in human leprosy: the role of HLA-D-identical peripheral lymphocytes and macrophages in the in vitro modulation of lymphoproliferative responses.
Nath I; Van Rood JJ; Mehra NK; Vaidya MC
Clin Exp Immunol; 1980 Nov; 42(2):203-10. PubMed ID: 6451335
[TBL] [Abstract][Full Text] [Related]
13. Mycobacterium leprae antigen-induced suppression of T cell proliferation in vitro.
Kaplan G; Gandhi RR; Weinstein DE; Levis WR; Patarroyo ME; Brennan PJ; Cohn ZA
J Immunol; 1987 May; 138(9):3028-34. PubMed ID: 3106496
[TBL] [Abstract][Full Text] [Related]
14. HLA and leprosy in the pre and postgenomic eras.
Geluk A; Ottenhoff TH
Hum Immunol; 2006 Jun; 67(6):439-45. PubMed ID: 16728267
[TBL] [Abstract][Full Text] [Related]
15. Suppression of delayed hypersensitivity skin reactions to tuberculin by M. leprae antigens in patients with lepromatous and tuberculoid leprosy.
Sengupta U; Sinha S; Ramu G; Lamb J; Ivanyi J
Clin Exp Immunol; 1987 Apr; 68(1):58-64. PubMed ID: 3308210
[TBL] [Abstract][Full Text] [Related]
16. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
[TBL] [Abstract][Full Text] [Related]
17. Phenolic glycolipid-I of Mycobacterium leprae induces general suppression of in vitro concanavalin A responses unrelated to leprosy type.
Prasad HK; Mishra RS; Nath I
J Exp Med; 1987 Jan; 165(1):239-44. PubMed ID: 3540178
[TBL] [Abstract][Full Text] [Related]
18. Definition of a human suppressor T-cell epitope.
Mutis T; Cornelisse YE; Datema G; van den Elsen PJ; Ottenhoff TH; de Vries RR
Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9456-60. PubMed ID: 7524076
[TBL] [Abstract][Full Text] [Related]
19. Comparison of various preparations of Mycobacterium leprae and other mycobacteria by lymphocyte stimulation.
Bjune G
Int J Lepr Other Mycobact Dis; 1978; 46(3-4):386-93. PubMed ID: 83309
[TBL] [Abstract][Full Text] [Related]
20. Cellular immune response to the cell walls of Mycobacterium leprae in leprosy patients and healthy subjects exposed to leprosy.
Roche PW; Neupane KD; Britton WJ
Clin Exp Immunol; 1992 Jul; 89(1):110-4. PubMed ID: 1628419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
